Australian biotech market today 22.05.09
Friday, 22 May, 2009
As of 3.30pm, Healthcare index is down 1% on the back of a general 1.3% drop experienced by the All Ordinaries sparked by global economic concerns.
CSL dropped 50c to $30.90 and ResMed (ASX:RMD) is also down fractionally, along with the rest of the market.
Cochlear (ASX:COH) bucked the trend by rising $1.01 to $53.01, as did Ramsay Health Care (ASX:RHC), which gained 1.1%.
Ansell (ASX:ANN) shed 39 cents to $8.21 after Barclays Group issued a notice of ceasing to be a substantial holder from 18 May.
Defective sperm doubles pre-eclampsia risk in IVF patients
A high proportion of the father's spermatozoa possessing DNA strand breaks is associated with...
Free meningococcal B vaccines coming to the NT
The Northern Territory Government has confirmed the rollout of a free meningococcal B vaccine...
Mouth bacteria linked to increased head and neck cancer risk
More than a dozen bacterial species that live in people's mouths have been linked to a...
